Trials / Completed
CompletedNCT04106778
DMT310-003 Topical in the Treatment of Acne Vulgaris
A Study of Tolerability, Safety, And Efficacy, Of DMT310 In Patients With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 181 (actual)
- Sponsor
- Dermata Therapeutics · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMT310 | Topical Powder |
| DRUG | Placebo | Placebo Topical Powder |
Timeline
- Start date
- 2019-10-10
- Primary completion
- 2020-05-04
- Completion
- 2020-05-04
- First posted
- 2019-09-27
- Last updated
- 2020-07-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04106778. Inclusion in this directory is not an endorsement.